{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["applications", "drug delivery", "herbal medicine", "nanocrystals", "nucleation and polymorphism", "preparation"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37687199", "DateCompleted": {"Year": "2023", "Month": "09", "Day": "11"}, "DateRevised": {"Year": "2023", "Month": "09", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "08", "Day": "31"}], "Language": ["eng"], "ELocationID": ["6370", "10.3390/molecules28176370"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "28", "Issue": "17", "PubDate": {"Year": "2023", "Month": "Aug", "Day": "31"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Herbal Medicine Nanocrystals: A Potential Novel Therapeutic Strategy.", "Abstract": {"AbstractText": ["Herbal medicines have gained recognition among physicians and patients due to their lower adverse effects compared to modern medicines. They are extensively used to treat various diseases, including cancer, cardiovascular issues, chronic inflammation, microbial contamination, diabetes, obesity, and hepatic disorders, among others. Unfortunately, the clinical application of herbal medicines is limited by their low solubility and inadequate bioavailability. Utilizing herbal medicines in the form of nanocrystals (herbal medicine nanocrystals) has shown potential in enhancing solubility and bioavailability by reducing the particle size, increasing the specific surface area, and modifying the absorption mechanisms. Multiple studies have demonstrated that these nanocrystals significantly improve drug efficacy by reducing toxicity and increasing bioavailability. This review comprehensively examines therapeutic approaches based on herbal medicine nanocrystals. It covers the preparation principles, key factors influencing nucleation and polymorphism control, applications, and limitations. The review underscores the importance of optimizing delivery systems for successful herbal medicine nanocrystal therapeutics. Furthermore, it discusses the main challenges and opportunities in developing herbal medicine nanocrystals for the purpose of treating conditions such as cancer, inflammatory diseases, cardiovascular disorders, mental and nervous diseases, and antimicrobial infections. In conclusion, we have deliberated regarding the hurdles and forthcoming outlook in the realm of nanotoxicity, in vivo kinetics, herbal ingredients as stabilizers of nanocrystals, and the potential for surmounting drug resistance through the utilization of nanocrystalline formulations in herbal medicine. We anticipate that this review will offer innovative insights into the development of herbal medicine nanocrystals as a promising and novel therapeutic strategy."]}, "AuthorList": [{"Identifier": ["0000-0001-5976-6383"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, West China Hospital, Sichuan University, Chengdu 610041, China."}], "LastName": "Guo", "ForeName": "Mengran", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Critical Care Medicine, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu 610041, China."}], "LastName": "Qin", "ForeName": "Shugang", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, West China Hospital, Sichuan University, Chengdu 610041, China."}], "LastName": "Wang", "ForeName": "Shiyan", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "First Affiliated Hospital of the Medical College, Shihezi University, Shihezi 832008, China."}], "LastName": "Sun", "ForeName": "Min", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "First Affiliated Hospital of the Medical College, Shihezi University, Shihezi 832008, China."}], "LastName": "Yang", "ForeName": "Huiling", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "First Affiliated Hospital of the Medical College, Shihezi University, Shihezi 832008, China."}], "LastName": "Wang", "ForeName": "Xinchun", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, West China Hospital, Sichuan University, Chengdu 610041, China."}], "LastName": "Fan", "ForeName": "Ping", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, West China Hospital, Sichuan University, Chengdu 610041, China."}], "LastName": "Jin", "ForeName": "Zhaohui", "Initials": "Z"}], "GrantList": [{"GrantID": "82104081", "Agency": "National Key Clinical Specialties Construction Program, the Youth Fund of National Natural Sci-ence Foundation of China", "Country": ""}, {"GrantID": "2023NSFSC1682", "Agency": "Sichuan Province Science and Technology Support Program", "Country": ""}, {"GrantID": "2022AB020", "Agency": "Science and Technology Project of Xinjiang Production and Construction Corps", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Herbal Medicine"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Biological Availability"}, {"QualifierName": [], "DescriptorName": "Nanoparticles"}, {"QualifierName": [], "DescriptorName": "Plant Extracts"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Ekor M. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety. Front. Pharmacol. 2014;4:177. doi: 10.3389/fphar.2013.00177.", "ArticleIdList": ["10.3389/fphar.2013.00177", "PMC3887317", "24454289"]}, {"Citation": "Caesar L.K., Cech N.B. Synergy and antagonism in natural product extracts: When 1 + 1 does not equal 2. Nat. Prod. Rep. 2019;36:869\u2013888. doi: 10.1039/C9NP00011A.", "ArticleIdList": ["10.1039/C9NP00011A", "PMC6820002", "31187844"]}, {"Citation": "Atanasov A.G., Waltenberger B., Pferschy-Wenzig E.M., Linder T., Wawrosch C., Uhrin P., Temml V., Wang L., Schwaiger S., Heiss E.H., et al. Discovery and resupply of pharmacologically active plant-derived natural products: A review. Biotechnol. Adv. 2015;33:1582\u20131614. doi: 10.1016/j.biotechadv.2015.08.001.", "ArticleIdList": ["10.1016/j.biotechadv.2015.08.001", "PMC4748402", "26281720"]}, {"Citation": "Teja P.K., Mithiya J., Kate A.S., Bairwa K., Chauthe S.K. Herbal nanomedicines: Recent advancements, challenges, opportunities and regulatory overview. Phytomedicine. 2022;96:153890. doi: 10.1016/j.phymed.2021.153890.", "ArticleIdList": ["10.1016/j.phymed.2021.153890", "35026510"]}, {"Citation": "Giordano A., Tommonaro G. Curcumin and Cancer. Nutrients. 2019;11:2376. doi: 10.3390/nu11102376.", "ArticleIdList": ["10.3390/nu11102376", "PMC6835707", "31590362"]}, {"Citation": "Singh L., Sharma S., Xu S., Tewari D., Fang J. Curcumin as a Natural Remedy for Atherosclerosis: A Pharmacological Review. Molecules. 2021;26:4036. doi: 10.3390/molecules26134036.", "ArticleIdList": ["10.3390/molecules26134036", "PMC8272048", "34279384"]}, {"Citation": "Zhang J., Hu K., Di L., Wang P., Liu Z., Zhang J., Yue P., Song W., Zhang J., Chen T., et al. Traditional herbal medicine and nanomedicine: Converging disciplines to improve therapeutic efficacy and human health. Adv. Drug Deliv. Rev. 2021;178:113964. doi: 10.1016/j.addr.2021.113964.", "ArticleIdList": ["10.1016/j.addr.2021.113964", "34499982"]}, {"Citation": "Patra J.K., Das G., Fraceto L.F., Campos E.V.R., Rodriguez-Torres M.D.P., Acosta-Torres L.S., Diaz-Torres L.A., Grillo R., Swamy M.K., Sharma S., et al. Nano based drug delivery systems: Recent developments and future prospects. J. Nanobiotechnol. 2018;16:71. doi: 10.1186/s12951-018-0392-8.", "ArticleIdList": ["10.1186/s12951-018-0392-8", "PMC6145203", "30231877"]}, {"Citation": "Singh S.K., Vaidya Y., Gulati M., Bhattacharya S., Garg V., Pandey N.K. Nanosuspension: Principles, Perspectives and Practices. Curr. Drug Deliv. 2016;13:1222\u20131246. doi: 10.2174/1567201813666160101120452.", "ArticleIdList": ["10.2174/1567201813666160101120452", "26721266"]}, {"Citation": "Keck C.M., Muller R.H. Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation. Eur. J. Pharm. Biopharm. 2006;62:3\u201316. doi: 10.1016/j.ejpb.2005.05.009.", "ArticleIdList": ["10.1016/j.ejpb.2005.05.009", "16129588"]}, {"Citation": "Guo M., Wei M., Li W., Guo M., Guo C., Ma M., Wang Y., Yang Z., Li M., Fu Q., et al. Impacts of particle shapes on the oral delivery of drug nanocrystals: Mucus permeation, transepithelial transport and bioavailability. J. Control. Release. 2019;307:64\u201375. doi: 10.1016/j.jconrel.2019.06.015.", "ArticleIdList": ["10.1016/j.jconrel.2019.06.015", "31207275"]}, {"Citation": "Guo M.R., Chen H.N., Zhang C., Zhang G.S., Wang Y.Z., Li P.C., Fu Q. Probing the particle shape effects on the biodistribution and antihyperlipidemic efficiency for oral lovastatin nanocrystals. J. Mol. Liq. 2021;324:114700. doi: 10.1016/j.molliq.2020.114700.", "ArticleIdList": ["10.1016/j.molliq.2020.114700"]}, {"Citation": "Zhang G., Wang Y., Zhang Z., He Z., Liu Y., Fu Q. FRET imaging revealed that nanocrystals enhanced drug oral absorption by dissolution rather than endocytosis: A case study of coumarin 6. J. Control. Release. 2021;332:225\u2013232. doi: 10.1016/j.jconrel.2021.02.025.", "ArticleIdList": ["10.1016/j.jconrel.2021.02.025", "33640408"]}, {"Citation": "Fu Q., Sun J., Ai X., Zhang P., Li M., Wang Y., Liu X., Sun Y., Sui X., Sun L., et al. Nimodipine nanocrystals for oral bioavailability improvement: Role of mesenteric lymph transport in the oral absorption. Int. J. Pharm. 2013;448:290\u2013297. doi: 10.1016/j.ijpharm.2013.01.065.", "ArticleIdList": ["10.1016/j.ijpharm.2013.01.065", "23384726"]}, {"Citation": "Guan W.H., Ma Y.Y., Ding S.J., Liu Y.C., Song Z.M., Liu X., Tang L.L., Wang Y.C. The technology for improving stability of nanosuspensions in drug delivery. J. Nanopart. Res. 2022;24:14. doi: 10.1007/s11051-022-05403-9.", "ArticleIdList": ["10.1007/s11051-022-05403-9"]}, {"Citation": "Wang Y., Zheng Y., Zhang L., Wang Q., Zhang D. Stability of nanosuspensions in drug delivery. J. Control. Release. 2013;172:1126\u20131141. doi: 10.1016/j.jconrel.2013.08.006.", "ArticleIdList": ["10.1016/j.jconrel.2013.08.006", "23954372"]}, {"Citation": "Chen M.L., John M., Lee S.L., Tyner K.M. Development Considerations for Nanocrystal Drug Products. AAPS J. 2017;19:642\u2013651. doi: 10.1208/s12248-017-0064-x.", "ArticleIdList": ["10.1208/s12248-017-0064-x", "28281194"]}, {"Citation": "Fan M., Geng S., Liu Y., Wang J., Wang Y., Zhong J., Yan Z., Yu L. Nanocrystal Technology as a Strategy to Improve Drug Bioavailability and Antitumor Efficacy for the Cancer Treatment. Curr. Pharm. Des. 2018;24:2416\u20132424. doi: 10.2174/1381612824666180515154109.", "ArticleIdList": ["10.2174/1381612824666180515154109", "29766787"]}, {"Citation": "Lee H., Bang J.B., Na Y.G., Lee J.Y., Cho C.W., Baek J.S., Lee H.K. Development and Evaluation of Tannic Acid-Coated Nanosuspension for Enhancing Oral Bioavailability of Curcumin. Pharmaceutics. 2021;13:1460. doi: 10.3390/pharmaceutics13091460.", "ArticleIdList": ["10.3390/pharmaceutics13091460", "PMC8468675", "34575537"]}, {"Citation": "Murakami Y., Shimoyama Y. Production of nanosuspension functionalized by chitosan using supercritical fluid extraction of emulsion. J. Supercrit. Fluids. 2017;128:121\u2013127. doi: 10.1016/j.supflu.2017.05.014.", "ArticleIdList": ["10.1016/j.supflu.2017.05.014"]}, {"Citation": "Sarkari M., Brown J., Chen X., Swinnea S., Williams R.O., III, Johnston K.P. Enhanced drug dissolution using evaporative precipitation into aqueous solution. Int. J. Pharm. 2002;243:17\u201331. doi: 10.1016/S0378-5173(02)00072-8.", "ArticleIdList": ["10.1016/S0378-5173(02)00072-8", "12176292"]}, {"Citation": "Gao L., Liu G., Kang J., Niu M., Wang Z., Wang H., Ma J., Wang X. Paclitaxel nanosuspensions coated with P-gp inhibitory surfactants: I. Acute toxicity and pharmacokinetics studies. Colloids Surf. B Biointerfaces. 2013;111:277\u2013281. doi: 10.1016/j.colsurfb.2013.06.004.", "ArticleIdList": ["10.1016/j.colsurfb.2013.06.004", "23838193"]}, {"Citation": "Bosselmann S., Nagao M., Chow K.T., Williams R.O., III Influence of formulation and processing variables on properties of itraconazole nanoparticles made by advanced evaporative precipitation into aqueous solution. AAPS PharmSciTech. 2012;13:949\u2013960. doi: 10.1208/s12249-012-9817-0.", "ArticleIdList": ["10.1208/s12249-012-9817-0", "PMC3429681", "22752680"]}, {"Citation": "Kakran M., Sahoo N.G., Li L., Judeh Z. Dissolution of artemisinin/polymer composite nanoparticles fabricated by evaporative precipitation of nanosuspension. J. Pharm. Pharmacol. 2010;62:413\u2013421. doi: 10.1211/jpp.62.04.0002.", "ArticleIdList": ["10.1211/jpp.62.04.0002", "20604829"]}, {"Citation": "Lu Y., Chen Y., Gemeinhart R.A., Wu W., Li T. Developing nanocrystals for cancer treatment. Nanomedicine. 2015;10:2537\u20132552. doi: 10.2217/nnm.15.73.", "ArticleIdList": ["10.2217/nnm.15.73", "26293310"]}, {"Citation": "Merisko-Liversidge E., Liversidge G.G. Nanosizing for oral and parenteral drug delivery: A perspective on formulating poorly-water soluble compounds using wet media milling technology. Adv. Drug Deliv. Rev. 2011;63:427\u2013440. doi: 10.1016/j.addr.2010.12.007.", "ArticleIdList": ["10.1016/j.addr.2010.12.007", "21223990"]}, {"Citation": "Lizonova D., Hladek F., Chvila S., Balaz A., Stankova S., Stepanek F. Surface stabilization determines macrophage uptake, cytotoxicity, and bioactivity of curcumin nanocrystals. Int. J. Pharm. 2022;626:122133. doi: 10.1016/j.ijpharm.2022.122133.", "ArticleIdList": ["10.1016/j.ijpharm.2022.122133", "36055446"]}, {"Citation": "Lou H., Gao L., Wei X., Zhang Z., Zheng D., Zhang D., Zhang X., Li Y., Zhang Q. Oridonin nanosuspension enhances anti-tumor efficacy in SMMC-7721 cells and H22 tumor bearing mice. Colloids Surf. B Biointerfaces. 2011;87:319\u2013325. doi: 10.1016/j.colsurfb.2011.05.037.", "ArticleIdList": ["10.1016/j.colsurfb.2011.05.037", "21676599"]}, {"Citation": "Yang X., Liu Y., Zhao Y., Han M., Guo Y., Kuang H., Wang X. A stabilizer-free and organic solvent-free method to prepare 10-hydroxycamptothecin nanocrystals: In vitro and in vivo evaluation. Int. J. Nanomed. 2016;11:2979\u20132994. doi: 10.2147/IJN.S102726.", "ArticleIdList": ["10.2147/IJN.S102726", "PMC4922823", "27382284"]}, {"Citation": "Meng T.T., Qiao F.X., Ma S.J., Gao T., Li L., Hou Y.H., Yang J.H. Exploring the influence factors and improvement strategies of drug polymorphic transformation combined kinetic and thermodynamic perspectives during the formation of nanosuspensions. Drug Dev. Ind. Pharm. 2021;47:1867\u20131880. doi: 10.1080/03639045.2022.2061988.", "ArticleIdList": ["10.1080/03639045.2022.2061988", "35362347"]}, {"Citation": "Dupont A., Guerain M., Danede F., Paccou L., Guinet Y., Hedoux A., Willart J.F. Kinetics and mechanism of polymorphic transformation of sorbitol under mechanical milling. Int. J. Pharm. 2020;590:119902. doi: 10.1016/j.ijpharm.2020.119902.", "ArticleIdList": ["10.1016/j.ijpharm.2020.119902", "32980510"]}, {"Citation": "Mazel V., Delplace C., Busignies V., Faivre V., Tchoreloff P., Yagoubi N. Polymorphic transformation of anhydrous caffeine under compression and grinding: A re-evaluation. Drug Dev. Ind. Pharm. 2011;37:832\u2013840. doi: 10.3109/03639045.2010.545416.", "ArticleIdList": ["10.3109/03639045.2010.545416", "21214492"]}, {"Citation": "Descamps M., Willart J.F. Perspectives on the amorphisation/milling relationship in pharmaceutical materials. Adv. Drug Deliv. Rev. 2016;100:51\u201366. doi: 10.1016/j.addr.2016.01.011.", "ArticleIdList": ["10.1016/j.addr.2016.01.011", "26826439"]}, {"Citation": "Aleandri S., Schonenberger M., Niederquell A., Kuentz M. Temperature-Induced Surface Effects on Drug Nanosuspensions. Pharm. Res. 2018;35:69. doi: 10.1007/s11095-017-2300-6.", "ArticleIdList": ["10.1007/s11095-017-2300-6", "29468420"]}, {"Citation": "Nandi S., Padrela L., Tajber L., Collas A. Nucleation kinetics-based solvent selection for the liquid antisolvent crystallization of a lipophilic intermediate. J. Mol. Liq. 2023;375:121306. doi: 10.1016/j.molliq.2023.121306.", "ArticleIdList": ["10.1016/j.molliq.2023.121306"]}, {"Citation": "Shariare M.H., Sharmin S., Jahan I., Reza H.M., Mohsin K. The impact of process parameters on carrier free paracetamol nanosuspension prepared using different stabilizers by antisolvent precipitation method. J. Drug Deliv. Sci. Technol. 2018;43:122\u2013128. doi: 10.1016/j.jddst.2017.10.001.", "ArticleIdList": ["10.1016/j.jddst.2017.10.001"]}, {"Citation": "Chen Z.J., Wu W., Lu Y. What is the future for nanocrystal-based drug-delivery systems? Ther. Deliv. 2020;11:225\u2013230. doi: 10.4155/tde-2020-0016.", "ArticleIdList": ["10.4155/tde-2020-0016", "32157960"]}, {"Citation": "Ahmadi Tehrani A., Omranpoor M.M., Vatanara A., Seyedabadi M., Ramezani V. Formation of nanosuspensions in bottom-up approach: Theories and optimization. Daru. 2019;27:451\u2013473. doi: 10.1007/s40199-018-00235-2.", "ArticleIdList": ["10.1007/s40199-018-00235-2", "PMC6593134", "30661188"]}, {"Citation": "Yang X., Ong T.C., Michaelis V.K., Heng S., Griffin R.G., Myerson A.S. Formation of Organic Molecular Nanocrystals under Soft Confinement. CrystEngComm. 2015;17:6044\u20136052. doi: 10.1039/C5CE01202C.", "ArticleIdList": ["10.1039/C5CE01202C", "PMC4544706", "26306076"]}, {"Citation": "Lindfors L., Forssen S., Westergren J., Olsson U. Nucleation and crystal growth in supersaturated solutions of a model drug. J. Colloid Interface Sci. 2008;325:404\u2013413. doi: 10.1016/j.jcis.2008.05.034.", "ArticleIdList": ["10.1016/j.jcis.2008.05.034", "18561941"]}, {"Citation": "Wang X.H., Liu Y., Shen C.Y., Shen B.D., Zhong R.N., Yuan H.L. Effect of particle size on in vitro and in vivo behavior of astilbin nanosuspensions. J. Drug Deliv. Sci. Technol. 2019;52:778\u2013783. doi: 10.1016/j.jddst.2019.05.005.", "ArticleIdList": ["10.1016/j.jddst.2019.05.005"]}, {"Citation": "Wang Y., Wang L., Liu Z., Zhang D., Zhang Q. In vivo evaluation of silybin nanosuspensions targeting liver. J. Biomed. Nanotechnol. 2012;8:760\u2013769. doi: 10.1166/jbn.2012.1444.", "ArticleIdList": ["10.1166/jbn.2012.1444", "22888746"]}, {"Citation": "Zheng D., Wang Y., Zhang D., Liu Z., Duan C., Jia L., Wang F., Liu Y., Liu G., Hao L., et al. In vitro antitumor activity of silybin nanosuspension in PC-3 cells. Cancer Lett. 2011;307:158\u2013164. doi: 10.1016/j.canlet.2011.03.028.", "ArticleIdList": ["10.1016/j.canlet.2011.03.028", "21507570"]}, {"Citation": "Shelar D.B., Pawar S.K., Vavia P.R. Fabrication of isradipine nanosuspension by anti-solvent microprecipitation-high-pressure homogenization method for enhancing dissolution rate and oral bioavailability. Drug Deliv. Transl. Res. 2013;3:384\u2013391. doi: 10.1007/s13346-012-0081-3.", "ArticleIdList": ["10.1007/s13346-012-0081-3", "25788346"]}, {"Citation": "Liu T., Muller R.H., Moschwitzer J.P. Effect of drug physico-chemical properties on the efficiency of top-down process and characterization of nanosuspension. Expert Opin. Drug Deliv. 2015;12:1741\u20131754. doi: 10.1517/17425247.2015.1057566.", "ArticleIdList": ["10.1517/17425247.2015.1057566", "26098043"]}, {"Citation": "Shin G.H., Li J., Cho J.H., Kim J.T., Park H.J. Enhancement of Curcumin Solubility by Phase Change from Crystalline to Amorphous in Cur-TPGS Nanosuspension. J. Food Sci. 2016;81:N494\u2013N501. doi: 10.1111/1750-3841.13208.", "ArticleIdList": ["10.1111/1750-3841.13208", "26766628"]}, {"Citation": "Liu T., Muller R.H., Moschwitzer J.P. Consideration of the solid state for resveratrol nanocrystal production. Powder Technol. 2018;332:63\u201369. doi: 10.1016/j.powtec.2018.03.028.", "ArticleIdList": ["10.1016/j.powtec.2018.03.028"]}, {"Citation": "Bellucci M.A., Marx A., Wang B., Fang L., Zhou Y., Greenwell C., Li Z., Becker A., Sun G., Brandenburg J.G., et al. Effect of Polymer Additives on the Crystal Habit of Metformin HCl. Small Methods. 2023;7:e2201692. doi: 10.1002/smtd.202201692.", "ArticleIdList": ["10.1002/smtd.202201692", "36965154"]}, {"Citation": "Nakanishi Y., Chang F.R., Liaw C.C., Wu Y.C., Bastow K.F., Lee K.H. Acetogenins as selective inhibitors of the human ovarian 1A9 tumor cell line. J. Med. Chem. 2003;46:3185\u20133188. doi: 10.1021/jm020548b.", "ArticleIdList": ["10.1021/jm020548b", "12852747"]}, {"Citation": "Hong J., Li Y., Li Y., Xiao Y., Kuang H., Wang X. Annonaceous acetogenins nanosuspensions stabilized by PCL-PEG block polymer: Significantly improved antitumor efficacy. Int. J. Nanomed. 2016;11:3239\u20133253. doi: 10.2147/IJN.S108143.", "ArticleIdList": ["10.2147/IJN.S108143", "PMC4957684", "27486323"]}, {"Citation": "Hopp D.C., Alali F.Q., Gu Z.M., McLaughlin J.L. Three new bioactive bis-adjacent THF-ring acetogenins from the bark of Annona squamosa. Bioorg. Med. Chem. 1998;6:569\u2013575. doi: 10.1016/S0968-0896(98)00018-2.", "ArticleIdList": ["10.1016/S0968-0896(98)00018-2", "9629470"]}, {"Citation": "Ahammadsahib K.I., Hollingworth R.M., Mcgovren J.P., Hui Y.H., Mclaughlin J.L. Mode of Action of Bullatacin\u2014A Potent Antitumor and Pesticidal Annonaceous Acetogenin. Life Sci. 1993;53:1113\u20131120. doi: 10.1016/0024-3205(93)90547-G.", "ArticleIdList": ["10.1016/0024-3205(93)90547-G", "8371627"]}, {"Citation": "Chen Y., Chen J.W., Li X. Cytotoxic Bistetrahydrofuran Annonaceous Acetogenins from the Seeds of Annona squamosa. J. Nat. Prod. 2011;74:2477\u20132481. doi: 10.1021/np200708q.", "ArticleIdList": ["10.1021/np200708q", "22011319"]}, {"Citation": "Oberlies N.H., Croy V.L., Harrison M.L., McLaughlin J.L. The Annonaceous acetogenin bullatacin is cytotoxic against multidrug-resistant human mammary adenocarcinoma cells. Cancer Lett. 1997;115:73\u201379. doi: 10.1016/S0304-3835(97)04716-2.", "ArticleIdList": ["10.1016/S0304-3835(97)04716-2", "9097981"]}, {"Citation": "Chen Y., Chen J.W., Zhai J.H., Wang Y., Wang S.L., Li X. Antitumor activity and toxicity relationship of annonaceous acetogenins. Food Chem. Toxicol. 2013;58:394\u2013400. doi: 10.1016/j.fct.2013.05.028.", "ArticleIdList": ["10.1016/j.fct.2013.05.028", "23712095"]}, {"Citation": "Fan Y., Peng A.H., He S.C., Shao X.M., Nie C.L., Chen L.J. Isogambogenic acid inhibits tumour angiogenesis by suppressing Rho GTPases and vascular endothelial growth factor receptor 2 signalling pathway. J. Chemother. 2013;25:298\u2013308. doi: 10.1179/1973947813Y.0000000079.", "ArticleIdList": ["10.1179/1973947813Y.0000000079", "24070138"]}, {"Citation": "Zhou J., Luo Y.H., Wang J.R., Lu B.B., Wang K.M., Tian Y. Gambogenic Acid Induction of Apoptosis in a Breast Cancer Cell Line. Asian Pac. J. Cancer Prev. 2013;14:7601\u20137605. doi: 10.7314/APJCP.2013.14.12.7601.", "ArticleIdList": ["10.7314/APJCP.2013.14.12.7601", "24460340"]}, {"Citation": "Wang M., Chen D., Cheng H., Li B., Yan F.G., Su J.J., Peng C., Sun M.L., Hu Y.W., Wang X.S., et al. Gambogenic Acid Kills Lung Cancer Cells through Aberrant Autophagy. PLoS ONE. 2014;9:e83604. doi: 10.1371/journal.pone.0083604.", "ArticleIdList": ["10.1371/journal.pone.0083604", "PMC3888381", "24427275"]}, {"Citation": "Chen R., Zhang H., Liu P., Wu X., Chen B. Gambogenic acid synergistically potentiates bortezomib-induced apoptosis in multiple myeloma. J. Cancer. 2017;8:839\u2013851. doi: 10.7150/jca.17657.", "ArticleIdList": ["10.7150/jca.17657", "PMC5381173", "28382147"]}, {"Citation": "Xu Q., Guo J., Chen W. Gambogenic acid reverses P-glycoprotein mediated multidrug resistance in HepG2/Adr cells and its underlying mechanism. Biochem. Biophys. Res. Commun. 2019;508:882\u2013888. doi: 10.1016/j.bbrc.2018.12.028.", "ArticleIdList": ["10.1016/j.bbrc.2018.12.028", "30538042"]}, {"Citation": "Yuan H., Li X., Zhang C., Pan W., Liang Y., Chen Y., Chen W., Liu L., Wang X. Nanosuspensions as delivery system for gambogenic acid: Characterization and in vitro/in vivo evaluation. Drug Deliv. 2016;23:2772\u20132779. doi: 10.3109/10717544.2015.1077294.", "ArticleIdList": ["10.3109/10717544.2015.1077294", "26292058"]}, {"Citation": "Li Q.Y., Zu Y.G., Shi R.Z., Yao L.P. Review Camptothecin: Current Perspectives. Curr. Med. Chem. 2006;13:2021\u20132039. doi: 10.2174/092986706777585004.", "ArticleIdList": ["10.2174/092986706777585004", "16842195"]}, {"Citation": "Yao Z., Wang W., Ning J., Zhang X., Zheng W., Qian Y., Fan C. Hydroxycamptothecin Inhibits Peritendinous Adhesion via the Endoplasmic Reticulum Stress-Dependent Apoptosis. Front. Pharmacol. 2019;10:967. doi: 10.3389/fphar.2019.00967.", "ArticleIdList": ["10.3389/fphar.2019.00967", "PMC6737834", "31551777"]}, {"Citation": "Zhou M., Zhang X., Yu C., Nan X., Chen X., Zhang X. Shape regulated anticancer activities and systematic toxicities of drug nanocrystals in vivo. Nanomedicine. 2016;12:181\u2013189. doi: 10.1016/j.nano.2015.09.006.", "ArticleIdList": ["10.1016/j.nano.2015.09.006", "26427356"]}, {"Citation": "Huang X., Zhu H.L. Resveratrol and its analogues: Promising antitumor agents. Anti-Cancer Agents Med. Chem. 2011;11:479\u2013490. doi: 10.2174/187152011795677427.", "ArticleIdList": ["10.2174/187152011795677427", "21524243"]}, {"Citation": "Bian P., Hu W., Liu C., Li L. Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K/AKT/mTOR pathway involved. Arch. Biochem. Biophys. 2020;689:108461. doi: 10.1016/j.abb.2020.108461.", "ArticleIdList": ["10.1016/j.abb.2020.108461", "32531316"]}, {"Citation": "Wang L., Liu Y., Zhao J., Li C., Zhou Y., Du J., Wang Y. In vitro and in vivo evaluation of targeting tumor with folate-based amphiphilic multifunctional stabilizer for resveratrol nanosuspensions. Colloids Surf. B Biointerfaces. 2017;160:462\u2013472. doi: 10.1016/j.colsurfb.2017.09.056.", "ArticleIdList": ["10.1016/j.colsurfb.2017.09.056", "28988124"]}, {"Citation": "Ancic D., Orsolic N., Odeh D., Tomasevic M., Pepic I., Ramic S. Resveratrol and its nanocrystals: A promising approach for cancer therapy? Toxicol. Appl. Pharmacol. 2022;435:115851. doi: 10.1016/j.taap.2021.115851.", "ArticleIdList": ["10.1016/j.taap.2021.115851", "34971666"]}, {"Citation": "Zhang Z., Zhang X., Xue W., Yangyang Y., Xu D., Zhao Y., Lou H. Effects of oridonin nanosuspension on cell proliferation and apoptosis of human prostatic carcinoma PC-3 cell line. Int. J. Nanomed. 2010;5:735\u2013742. doi: 10.2147/IJN.S13537.", "ArticleIdList": ["10.2147/IJN.S13537", "PMC2962269", "21042419"]}, {"Citation": "Tang X., Sun J., Ge T., Zhang K., Gui Q., Zhang S., Chen W. PEGylated liposomes as delivery systems for Gambogenic acid: Characterization and in vitro/in vivo evaluation. Colloids Surf. B Biointerfaces. 2018;172:26\u201336. doi: 10.1016/j.colsurfb.2018.08.022.", "ArticleIdList": ["10.1016/j.colsurfb.2018.08.022", "30125771"]}, {"Citation": "Qiao F., Zhao Y., Mai Y., Guo J., Dong L., Zhang W., Yang J. Isoliquiritigenin Nanosuspension Enhances Cytostatic Effects in A549 Lung Cancer Cells. Planta Med. 2020;86:538\u2013547. doi: 10.1055/a-1134-3378.", "ArticleIdList": ["10.1055/a-1134-3378", "32294789"]}, {"Citation": "Li W., Das S., Ng K.Y., Heng P.W. Formulation, biological and pharmacokinetic studies of sucrose ester-stabilized nanosuspensions of oleanolic Acid. Pharm. Res. 2011;28:2020\u20132033. doi: 10.1007/s11095-011-0428-3.", "ArticleIdList": ["10.1007/s11095-011-0428-3", "21479757"]}, {"Citation": "Huang T., Wang Y., Shen Y., Ao H., Guo Y., Han M., Wang X. Preparation of high drug-loading celastrol nanosuspensions and their anti-breast cancer activities in vitro and in vivo. Sci. Rep. 2020;10:8851. doi: 10.1038/s41598-020-65773-9.", "ArticleIdList": ["10.1038/s41598-020-65773-9", "PMC7264310", "32483248"]}, {"Citation": "Yang L., Hong J., Di J., Guo Y., Han M., Liu M., Wang X. 10-Hydroxycamptothecin (HCPT) nanosuspensions stabilized by mPEG(1000)-HCPT conjugate: High stabilizing efficiency and improved antitumor efficacy. Int. J. Nanomed. 2017;12:3681\u20133695. doi: 10.2147/IJN.S134005.", "ArticleIdList": ["10.2147/IJN.S134005", "PMC5439984", "28553107"]}, {"Citation": "Sun M., Gao Y., Pei Y., Guo C., Li H., Cao F., Yu A., Zhai G. Development of nanosuspension formulation for oral delivery of quercetin. J. Biomed. Nanotechnol. 2010;6:325\u2013332. doi: 10.1166/jbn.2010.1133.", "ArticleIdList": ["10.1166/jbn.2010.1133", "21323105"]}, {"Citation": "Pengnam S., Charoensuksai P., Yingyongnarongkul B.E., Saeeng R., Uludag H., Patrojanasophon P., Opanasopit P., Plianwong S. siRNA Targeting Mcl-1 Potentiates the Anticancer Activity of Andrographolide Nanosuspensions via Apoptosis in Breast Cancer Cells. Pharmaceutics. 2022;14:1196. doi: 10.3390/pharmaceutics14061196.", "ArticleIdList": ["10.3390/pharmaceutics14061196", "PMC9230779", "35745769"]}, {"Citation": "Hong J.Y., Liu Y.Y., Xiao Y., Yang X.F., Su W.J., Zhang M.Z., Liao Y.H., Kuang H.X., Wang X.T. High drug payload curcumin nanosuspensions stabilized by mPEG-DSPE and SPC: In vitro and in vivo evaluation. Drug Deliv. 2017;24:109\u2013120. doi: 10.1080/10717544.2016.1233589.", "ArticleIdList": ["10.1080/10717544.2016.1233589", "PMC8253124", "28155567"]}, {"Citation": "Gao Y., Li Z.G., Sun M., Li H.L., Guo C.Y., Cui J., Li A.G., Cao F.L., Xi Y.W., Lou H.X., et al. Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer. Drug Dev. Ind. Pharm. 2010;36:1225\u20131234. doi: 10.3109/03639041003695139.", "ArticleIdList": ["10.3109/03639041003695139", "20545506"]}, {"Citation": "Jin L., Zeng W., Zhang F., Zhang C., Liang W. Naringenin Ameliorates Acute Inflammation by Regulating Intracellular Cytokine Degradation. J. Immunol. 2017;199:3466\u20133477. doi: 10.4049/jimmunol.1602016.", "ArticleIdList": ["10.4049/jimmunol.1602016", "28993518"]}, {"Citation": "El-Shitany N.A., Eid B.G. Icariin modulates carrageenan-induced acute inflammation through HO-1/Nrf2 and NF-kB signaling pathways. Biomed. Pharmacother. 2019;120:109567. doi: 10.1016/j.biopha.2019.109567.", "ArticleIdList": ["10.1016/j.biopha.2019.109567", "31670031"]}, {"Citation": "Guo Y., Wang S., Wang Y., Zhu T. Silymarin improved diet-induced liver damage and insulin resistance by decreasing inflammation in mice. Pharm. Biol. 2016;54:2995\u20133000. doi: 10.1080/13880209.2016.1199042.", "ArticleIdList": ["10.1080/13880209.2016.1199042", "27387273"]}, {"Citation": "Yardim A., Kucukler S., Ozdemir S., Comakli S., Caglayan C., Kandemir F.M., Celik H. Silymarin alleviates docetaxel-induced central and peripheral neurotoxicity by reducing oxidative stress, inflammation and apoptosis in rats. Gene. 2021;769:145239. doi: 10.1016/j.gene.2020.145239.", "ArticleIdList": ["10.1016/j.gene.2020.145239", "33069805"]}, {"Citation": "Gera S., Sampathi S., Maddukuri S., Dodoala S., Junnuthula V., Dyawanapelly S. Therapeutic Potential of Naringenin Nanosuspension: In Vitro and In Vivo Anti-Osteoporotic Studies. Pharmaceutics. 2022;14:1449. doi: 10.3390/pharmaceutics14071449.", "ArticleIdList": ["10.3390/pharmaceutics14071449", "PMC9323949", "35890343"]}, {"Citation": "Dong Z.Q., Wang X.T., Wang M.Y., Wang R., Meng Z., Wang X.T., Yu B., Han M.H., Guo Y.F. Optimization of Naringenin Nanoparticles to Improve the Antitussive Effects on Post-Infectious Cough. Molecules. 2022;27:3736. doi: 10.3390/molecules27123736.", "ArticleIdList": ["10.3390/molecules27123736", "PMC9228777", "35744861"]}, {"Citation": "Li Y., Sun S.P., Chang Q., Zhang L., Wang G.N., Chen W.X., Miao X.Q., Zheng Y. A Strategy for the Improvement of the Bioavailability and Antiosteoporosis Activity of BCS IV Flavonoid Glycosides through the Formulation of Their Lipophilic Aglycone into Nanocrystals. Mol. Pharm. 2013;10:2534\u20132542. doi: 10.1021/mp300688t.", "ArticleIdList": ["10.1021/mp300688t", "23659498"]}, {"Citation": "Li H.M., Zhuo H.Y., Yin D., Li W., Zhang Y.M., Li P., Zou L. Intra-Articular Injection of a Nanosuspension of Tetramethylpyrazine Dihydroxynaphthalenate for Stronger and Longer-Lasting Effects Against Osteoarthritis. J. Biomed. Nanotechnol. 2021;17:1199\u20131207. doi: 10.1166/jbn.2021.3094.", "ArticleIdList": ["10.1166/jbn.2021.3094", "34167632"]}, {"Citation": "Casula L., Lai F., Pini E., Valenti D., Sinico C., Cardia M.C., Marceddu S., Ailuno G., Fadda A.M. Pulmonary Delivery of Curcumin and Beclomethasone Dipropionate in a Multicomponent Nanosuspension for the Treatment of Bronchial Asthma. Pharmaceutics. 2021;13:1300. doi: 10.3390/pharmaceutics13081300.", "ArticleIdList": ["10.3390/pharmaceutics13081300", "PMC8401312", "34452261"]}, {"Citation": "Mishra S.B., Pandey H., Pandey A.C. Nanosuspension of Phyllanthus amarus extract for improving oral bioavailability and prevention of paracetamol induced hepatotoxicity in Sprague-Dawley rats. Adv. Nat. Sci. Nanosci. Nanotechnol. 2013;4:035007. doi: 10.1088/2043-6262/4/3/035007.", "ArticleIdList": ["10.1088/2043-6262/4/3/035007"]}, {"Citation": "Ibrahim A.H., Rosqvist E., Smatt J.H., Ibrahim H.M., Ismael H.R., Afouna M.I., Samy A.M., Rosenholm J.M. Formulation and optimization of lyophilized nanosuspension tablets to improve the physicochemical properties and provide immediate release of silymarin. Int. J. Pharm. 2019;563:217\u2013227. doi: 10.1016/j.ijpharm.2019.03.064.", "ArticleIdList": ["10.1016/j.ijpharm.2019.03.064", "30946894"]}, {"Citation": "Qiao H.Z., Chen L.H., Rui T.Q., Wang J.X., Chen T., Fu T.M., Li J.S., Di L.Q. Fabrication and in vitro/in vivo evaluation of amorphous andrographolide nanosuspensions stabilized by D-alpha-tocopheryl polyethylene glycol 1000 succinate/sodium lauryl sulfate. Int. J. Nanomed. 2017;12:1033\u20131046. doi: 10.2147/IJN.S120887.", "ArticleIdList": ["10.2147/IJN.S120887", "PMC5304988", "28223797"]}, {"Citation": "Koonrungsesomboon N., Karbwang J. Ethical considerations in clinical research on herbal medicine for prevention of cardiovascular disease in the ageing. Phytomedicine. 2016;23:1090\u20131094. doi: 10.1016/j.phymed.2015.10.017.", "ArticleIdList": ["10.1016/j.phymed.2015.10.017", "26776958"]}, {"Citation": "Shaito A., Thuan D.T.B., Phu H.T., Nguyen T.H.D., Hasan H., Halabi S., Abdelhady S., Nasrallah G.K., Eid A.H., Pintus G. Herbal Medicine for Cardiovascular Diseases: Efficacy, Mechanisms, and Safety. Front. Pharmacol. 2020;11:422. doi: 10.3389/fphar.2020.00422.", "ArticleIdList": ["10.3389/fphar.2020.00422", "PMC7155419", "32317975"]}, {"Citation": "Wang M.Q., Wang S.Z., Goel V., Ling L., Shan J. Anti-Oxidant Activity of Different Herbal Extracts Used in Traditional Chinese Medicine for the Treatment of Cardiovascular Disease. Pharm. Biol. 2010;48:29\u201330."}, {"Citation": "Lee T.Y., Chang C.C., Lu W.J., Yen T.L., Lin K.H., Geraldine P., Li J.Y., Sheu J.R. Honokiol as a specific collagen receptor glycoprotein VI antagonist on human platelets: Functional ex vivo and in vivo studies. Sci. Rep. 2017;7:40002. doi: 10.1038/srep40002.", "ArticleIdList": ["10.1038/srep40002", "PMC5213647", "28054640"]}, {"Citation": "Jayakumari N.R., Rajendran R.S., Sivasailam A., Parambil S.T., Reghuvaran A.C., Sreelatha H.V., Gopala S. Honokiol regulates mitochondrial substrate utilization and cellular fatty acid metabolism in diabetic mice heart. Eur. J. Pharmacol. 2021;896:173918. doi: 10.1016/j.ejphar.2021.173918.", "ArticleIdList": ["10.1016/j.ejphar.2021.173918", "33529726"]}, {"Citation": "Elbarbry F., Moshirian N. The Modulation of Arachidonic Acid Metabolism and Blood Pressure-Lowering Effect of Honokiol in Spontaneously Hypertensive Rats. Molecules. 2022;27:3396. doi: 10.3390/molecules27113396.", "ArticleIdList": ["10.3390/molecules27113396", "PMC9182499", "35684335"]}, {"Citation": "Han M.H., Yu X., Guo Y.F., Wang Y.H., Kuang H.X., Wang X.T. Honokiol nanosuspensions: Preparation, increased oral bioavailability and dramatically enhanced biodistribution in the cardio-cerebro-vascular system. Colloids Surf. B Biointerfaces. 2014;116:114\u2013120. doi: 10.1016/j.colsurfb.2013.12.056.", "ArticleIdList": ["10.1016/j.colsurfb.2013.12.056", "24448177"]}, {"Citation": "Wang Z.P., Wu J.B., Zhou Q., Wang Y.F., Chen T.S. Berberine Nanosuspension Enhances Hypoglycemic Efficacy on Streptozotocin Induced Diabetic C57BL/6 Mice. Evid.-Based Complement. Altern. Med. 2015;2015:239749. doi: 10.1155/2015/239749.", "ArticleIdList": ["10.1155/2015/239749", "PMC4381853", "25866534"]}, {"Citation": "Rui T.Q., Zhang L., Qiao H.Z., Huang P., Qian S., Li J.S., Chen Z.P., Fu T.M., Di L.Q., Cai B.C. Preparation and Physicochemical and Pharmacokinetic Characterization of Ginkgo Lactone Nanosuspensions for Antiplatelet Aggregation. J. Pharm. Sci. 2016;105:242\u2013249. doi: 10.1016/j.xphs.2015.10.002.", "ArticleIdList": ["10.1016/j.xphs.2015.10.002", "26852855"]}, {"Citation": "Zhao X., Wang W., Zu Y., Zhang Y., Li Y., Sun W., Shan C., Ge Y. Preparation and characterization of betulin nanoparticles for oral hypoglycemic drug by antisolvent precipitation. Drug Deliv. 2014;21:467\u2013479. doi: 10.3109/10717544.2014.881438.", "ArticleIdList": ["10.3109/10717544.2014.881438", "24479653"]}, {"Citation": "Singh A.K., Pandey H., Ramteke P.W., Mishra S.B. Nano-suspension of ursolic acid for improving oral bioavailability and attenuation of type II diabetes: A histopathological investigation. Biocatal. Agric. Biotechnol. 2019;22:101433. doi: 10.1016/j.bcab.2019.101433.", "ArticleIdList": ["10.1016/j.bcab.2019.101433"]}, {"Citation": "Zhang T., Li X.X., Xu J.W., Shao J.B., Ding M.H., Shi S.L. Preparation, Characterization, and Evaluation of Breviscapine Nanosuspension and Its Freeze-Dried Powder. Pharmaceutics. 2022;14:923. doi: 10.3390/pharmaceutics14050923.", "ArticleIdList": ["10.3390/pharmaceutics14050923", "PMC9143020", "35631508"]}, {"Citation": "Li R.L., Wang L.Y., Duan H.X., Zhang Q., Guo X., Wu C., Peng W. Regulation of mitochondrial dysfunction induced cell apoptosis is a potential therapeutic strategy for herbal medicine to treat neurodegenerative diseases. Front. Pharmacol. 2022;13:937289. doi: 10.3389/fphar.2022.937289.", "ArticleIdList": ["10.3389/fphar.2022.937289", "PMC9535092", "36210852"]}, {"Citation": "Yin R., Xue J., Tan Y., Fang C., Hu C., Yang Q., Mei X., Qi D. The Positive Role and Mechanism of Herbal Medicine in Parkinson\u2019s Disease. Oxidative Med. Cell. Longev. 2021;2021:9923331. doi: 10.1155/2021/9923331.", "ArticleIdList": ["10.1155/2021/9923331", "PMC8457986", "34567415"]}, {"Citation": "Li L., Zhang Q.G., Lai L.Y., Wen X.J., Zheng T., Cheung C.W., Zhou S.Q., Xu S.Y. Neuroprotective Effect of Ginkgolide B on Bupivacaine-Induced Apoptosis in SH-SY5Y Cells. Oxidative Med. Cell. Longev. 2013;2013:159864. doi: 10.1155/2013/159864.", "ArticleIdList": ["10.1155/2013/159864", "PMC3818975", "24228138"]}, {"Citation": "Hua J., Yin N., Yang B.B., Zhang J., Ding J.H., Fan Y., Hu G. Ginkgolide B and bilobalide ameliorate neural cell apoptosis in alpha-synuclein aggregates. Biomed. Pharmacother. 2017;96:792\u2013797. doi: 10.1016/j.biopha.2017.10.050.", "ArticleIdList": ["10.1016/j.biopha.2017.10.050", "29054095"]}, {"Citation": "Liu Y., Liu W., Xiong S., Luo J.S., Li Y., Zhao Y.Y., Wang Q., Zhang Z.X., Chen X.J., Chen T.K. Highly stabilized nanocrystals delivering Ginkgolide B in protecting against the Parkinson\u2019s disease. Int. J. Pharm. 2020;577:119053. doi: 10.1016/j.ijpharm.2020.119053.", "ArticleIdList": ["10.1016/j.ijpharm.2020.119053", "31981707"]}, {"Citation": "Stahr P.L., Grewal R., Eckert G.P., Keck C.M. Investigating hesperetin nanocrystals with tailor-made sizes for the prevention and treatment of Alzheimer\u2019s disease. Drug Deliv. Transl. Res. 2021;11:659\u2013674. doi: 10.1007/s13346-020-00888-0.", "ArticleIdList": ["10.1007/s13346-020-00888-0", "PMC7987607", "33433841"]}, {"Citation": "Kakran M., Sahoo N.G., Li L. Dissolution enhancement of quercetin through nanofabrication, complexation, and solid dispersion. Colloids Surf. B Biointerfaces. 2011;88:121\u2013130. doi: 10.1016/j.colsurfb.2011.06.020.", "ArticleIdList": ["10.1016/j.colsurfb.2011.06.020", "21764266"]}, {"Citation": "Ghaffafi F., Moghaddam A.H., Zare M. Neuroprotective Effect of Quercetin Nanocrystal in a 6-Hydroxydopamine Model of Parkinson Disease: Biochemical and Behavioral Evidence. Basic Clin. Neurosci. 2018;9:317\u2013324. doi: 10.32598/bcn.9.5.317.", "ArticleIdList": ["10.32598/bcn.9.5.317", "PMC6360495", "30719246"]}, {"Citation": "Chen T.K., Li C.W., Li Y., Yi X., Lee S.M.Y., Zheng Y. Oral Delivery of a Nanocrystal Formulation of Schisantherin A with Improved Bioavailability and Brain Delivery for the Treatment of Parkinson\u2019s Disease. Mol. Pharm. 2016;13:3864\u20133875. doi: 10.1021/acs.molpharmaceut.6b00644.", "ArticleIdList": ["10.1021/acs.molpharmaceut.6b00644", "27740776"]}, {"Citation": "Babylon L., Grewal R., Stahr P.L., Eckert R.W., Keck C.M., Eckert G.P. Hesperetin Nanocrystals Improve Mitochondrial Function in a Cell Model of Early Alzheimer Disease. Antioxidants. 2021;10:1003. doi: 10.3390/antiox10071003.", "ArticleIdList": ["10.3390/antiox10071003", "PMC8300699", "34201544"]}, {"Citation": "Wei X.L., Han Y.R., Quan L.H., Liu C.Y., Liao Y.H. Oily nanosuspension for long-acting intramuscular delivery of curcumin didecanoate prodrug: Preparation, characterization and in vivo evaluation. Eur. J. Pharm. Sci. 2013;49:286\u2013293. doi: 10.1016/j.ejps.2013.03.010.", "ArticleIdList": ["10.1016/j.ejps.2013.03.010", "23542494"]}, {"Citation": "Ang L., Song E., Zhang J., Lee H.W., Lee M.S. Herbal medicine for COVID-19: An overview of systematic reviews and meta-analysis. Phytomedicine. 2022;102:154136. doi: 10.1016/j.phymed.2022.154136.", "ArticleIdList": ["10.1016/j.phymed.2022.154136", "PMC9045877", "35550224"]}, {"Citation": "Yu M., Jin X., Liang C., Bu F., Pan D., He Q., Ming Y., Little P., Du H., Liang S., et al. Berberine for diarrhea in children and adults: A systematic review and meta-analysis. Ther. Adv. Gastroenterol. 2020;13:1756284820961299. doi: 10.1177/1756284820961299.", "ArticleIdList": ["10.1177/1756284820961299", "PMC7586028", "33149763"]}, {"Citation": "Sahibzada M.U.K., Sadiq A., Faidah H.S., Khurram M., Amin M.U., Haseeb A., Kakar M. Berberine nanoparticles with enhanced in vitro bioavailability: Characterization and antimicrobial activity. Drug Des. Dev. Ther. 2018;12:303\u2013312. doi: 10.2147/DDDT.S156123.", "ArticleIdList": ["10.2147/DDDT.S156123", "PMC5817421", "29491706"]}, {"Citation": "Guo J.J., Yue P.F., Lv J.L., Han J., Fu S.S., Jin S.X., Jin S.Y., Yuan H.L. Development and in vivo/in vitro evaluation of novel herpetrione nanosuspension. Int. J. Pharm. 2013;441:227\u2013233. doi: 10.1016/j.ijpharm.2012.11.039.", "ArticleIdList": ["10.1016/j.ijpharm.2012.11.039", "23220096"]}, {"Citation": "Marchese A., Orhan I.E., Daglia M., Barbieri R., Di Lorenzo A., Nabavi S.F., Gortzi O., Izadi M., Nabavi S.M. Antibacterial and antifungal activities of thymol: A brief review of the literature. Food Chem. 2016;210:402\u2013414. doi: 10.1016/j.foodchem.2016.04.111.", "ArticleIdList": ["10.1016/j.foodchem.2016.04.111", "27211664"]}, {"Citation": "Zhou W., Zhang Y., Li R.Y., Peng S.F., Ruan R., Li J.H., Liu W. Fabrication of Caseinate Stabilized Thymol Nanosuspensions via the pH-Driven Method: Enhancement in Water Solubility of Thymol. Foods. 2021;10:1074. doi: 10.3390/foods10051074.", "ArticleIdList": ["10.3390/foods10051074", "PMC8151133", "34066210"]}, {"Citation": "Lai F., Pireddu R., Corrias F., Fadda A.M., Valenti D., Pini E., Sinico C. Nanosuspension improves tretinoin photostability and delivery to the skin. Int. J. Pharm. 2013;458:104\u2013109. doi: 10.1016/j.ijpharm.2013.10.007.", "ArticleIdList": ["10.1016/j.ijpharm.2013.10.007", "24135683"]}, {"Citation": "Zong R., Ruan H.A., Zhu W.Z., Zhang P., Feng Z.J., Liu C.M., Fan S.H., Liang H.M., Li J. Curcumin nanocrystals with tunable surface zeta potential: Preparation, characterization and antibacterial study. J. Drug Deliv. Sci. Technol. 2022;76:103771. doi: 10.1016/j.jddst.2022.103771.", "ArticleIdList": ["10.1016/j.jddst.2022.103771"]}, {"Citation": "Sahar P., Ali T., Naeem M., Hussain F. Nanotechnology approach for exploring the enhanced bioactivities, biochemical characterisation and phytochemistry of freshly prepared Mentha arvensis L. nanosuspensions. Phytochem. Anal. 2022 doi: 10.1002/pca.3189.", "ArticleIdList": ["10.1002/pca.3189", "36453173"]}, {"Citation": "Fujimura H., Komasaka T., Tomari T., Kitano Y., Takekawa K. Nanosuspension formulations of poorly water-soluble compounds for intravenous administration in exploratory toxicity studies: In vitro and in vivo evaluation. J. Appl. Toxicol. 2016;36:1259\u20131267. doi: 10.1002/jat.3280.", "ArticleIdList": ["10.1002/jat.3280", "26849104"]}, {"Citation": "Karami Z., Bidgoli S.A., Zanjani M.S., Arabshahi P., Gazori T., Hamidi M. Pharmacokinetics and repeated dose 28-day oral toxicity studies of acetaminophen nanosuspension. J. Biomed. Mater. Res. Part B. 2023;111:1687\u20131696. doi: 10.1002/jbm.b.35266.", "ArticleIdList": ["10.1002/jbm.b.35266", "37246876"]}, {"Citation": "Khanna P., Ong C., Bay B.H., Baeg G.H. Nanotoxicity: An Interplay of Oxidative Stress, Inflammation and Cell Death. Nanomaterials. 2015;5:1163\u20131180. doi: 10.3390/nano5031163.", "ArticleIdList": ["10.3390/nano5031163", "PMC5304638", "28347058"]}, {"Citation": "Ng C.T., Yu L.E., Ong C.N., Bay B.H., Baeg G.H. The use of Drosophila melanogaster as a model organism to study immune-nanotoxicity. Nanotoxicology. 2019;13:429\u2013446. doi: 10.1080/17435390.2018.1546413.", "ArticleIdList": ["10.1080/17435390.2018.1546413", "30451554"]}, {"Citation": "Muller R.H., Gohla S., Keck C.M. State of the art of nanocrystals\u2014Special features, production, nanotoxicology aspects and intracellular delivery. Eur. J. Pharm. Biopharm. 2011;78:1\u20139. doi: 10.1016/j.ejpb.2011.01.007.", "ArticleIdList": ["10.1016/j.ejpb.2011.01.007", "21266197"]}, {"Citation": "Doshi N., Mitragotri S. Needle-shaped polymeric particles induce transient disruption of cell membranes. J. R. Soc. Interface. 2010;7:S403\u2013S410. doi: 10.1098/rsif.2010.0134.focus.", "ArticleIdList": ["10.1098/rsif.2010.0134.focus", "PMC2943891", "20504803"]}, {"Citation": "Zhang B.K., Lung P.S., Zhao S.S., Chu Z.Q., Chrzanowski W., Li Q. Shape dependent cytotoxicity of PLGA-PEG nanoparticles on human cells. Sci. Rep. 2017;7:7315. doi: 10.1038/s41598-017-07588-9.", "ArticleIdList": ["10.1038/s41598-017-07588-9", "PMC5544670", "28779154"]}, {"Citation": "Wang T., Qi J., Ding N., Dong X., Zhao W., Lu Y., Wang C., Wu W. Tracking translocation of self-discriminating curcumin hybrid nanocrystals following intravenous delivery. Int. J. Pharm. 2018;546:10\u201319. doi: 10.1016/j.ijpharm.2018.05.020.", "ArticleIdList": ["10.1016/j.ijpharm.2018.05.020", "29751141"]}, {"Citation": "Shen C., Yang Y., Shen B., Xie Y., Qi J., Dong X., Zhao W., Zhu W., Wu W., Yuan H., et al. Self-discriminating fluorescent hybrid nanocrystals: Efficient and accurate tracking of translocation via oral delivery. Nanoscale. 2017;10:436\u2013450. doi: 10.1039/C7NR06052A.", "ArticleIdList": ["10.1039/C7NR06052A", "29227499"]}, {"Citation": "Qiao Y.H., Wei Z.H., Qin T.T., Song R.F., Yu Z.Q., Yuan Q., Du J., Zeng Q.B., Zong L.L., Duan S.F., et al. Combined nanosuspensions from two natural active ingredients for cancer therapy with reduced side effects. Chin. Chem. Lett. 2021;32:2877\u20132881. doi: 10.1016/j.cclet.2021.03.049.", "ArticleIdList": ["10.1016/j.cclet.2021.03.049"]}, {"Citation": "Herman A., Herman A.P. Herbal Products and Their Active Constituents Used Alone and in Combination with Antibiotics against Multidrug-Resistant Bacteria. Planta Med. 2022;89:168\u2013182. doi: 10.1055/a-1890-5559.", "ArticleIdList": ["10.1055/a-1890-5559", "35995069"]}, {"Citation": "Kathpalia H., Juvekar S., Mohanraj K., Apsingekar M., Shidhaye S. Investigation of pre-clinical pharmacokinetic parameters of atovaquone nanosuspension prepared using a pH-based precipitation method and its pharmacodynamic properties in a novel artemisinin combination. J. Glob. Antimicrob. Resist. 2020;22:248\u2013256. doi: 10.1016/j.jgar.2020.02.018.", "ArticleIdList": ["10.1016/j.jgar.2020.02.018", "32119990"]}, {"Citation": "Siram K., Raghavan C.V., Marslin G., Rahman H., Selvaraj D., Balakumar K., Franklin G. Quillaja saponin: A prospective emulsifier for the preparation of solid lipid nanoparticles. Colloids Surf. B Biointerfaces. 2016;147:274\u2013280. doi: 10.1016/j.colsurfb.2016.07.065.", "ArticleIdList": ["10.1016/j.colsurfb.2016.07.065", "27521748"]}, {"Citation": "Chen Y.C., Liu Y., Xu J.N., Xie Y.B., Zheng Q., Yue P.F., Yang M. A Natural Triterpenoid Saponin as Multifunctional Stabilizer for Drug Nanosuspension Powder. Aaps Pharmscitech. 2017;18:2744\u20132753. doi: 10.1208/s12249-017-0756-7.", "ArticleIdList": ["10.1208/s12249-017-0756-7", "28341935"]}, {"Citation": "Long J.Y., Song J.W., Zhang X.M., Deng M., Xie L., Zhang L.L., Li X.F. Tea saponins as natural stabilizers for the production of hesperidin nanosuspensions. Int. J. Pharm. 2020;583:119406. doi: 10.1016/j.ijpharm.2020.119406.", "ArticleIdList": ["10.1016/j.ijpharm.2020.119406", "32387309"]}, {"Citation": "Chen H.J., Deng M., Xie L., Liu K., Zhang X.M., Li X.F. Preparation and characterization of quercetin nanosuspensions using gypenosides as novel stabilizers. J. Drug Deliv. Sci. Technol. 2022;67:102962. doi: 10.1016/j.jddst.2021.102962.", "ArticleIdList": ["10.1016/j.jddst.2021.102962"]}, {"Citation": "Suo Z.L., Sun Q.M., Peng X., Zhang S.S., Gan N., Zhao L.D., Yuan N., Zhang Y.K., Li H. Lentinan as a natural stabilizer with bioactivities for preparation of drug-drug nanosuspensions. Int. J. Biol. Macromol. 2021;184:101\u2013108. doi: 10.1016/j.ijbiomac.2021.06.056.", "ArticleIdList": ["10.1016/j.ijbiomac.2021.06.056", "34119545"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "7", "Day": "15"}, {"Year": "2023", "Month": "8", "Day": "11"}, {"Year": "2023", "Month": "8", "Day": "25"}, {"Year": "2023", "Month": "9", "Day": "11", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "9", "Day": "9", "Hour": "11", "Minute": "44"}, {"Year": "2023", "Month": "9", "Day": "9", "Hour": "1", "Minute": "18"}, {"Year": "2023", "Month": "8", "Day": "31"}], "PublicationStatus": "epublish", "ArticleIdList": ["37687199", "PMC10489021", "10.3390/molecules28176370", "molecules28176370"]}}], "PubmedBookArticle": []}